As a transcription factor, ARID3A participates in many cellular processes and is reported to promote the progression of tumors such as ovarian cancer, colorectal cancer, and nasopharyngeal cancer (Dausinas et al., 2020; Tang et al., 2020). Here, ARID3A is linked to nasopharyngeal carcinoma.